However, a recent study found that there was no difference in the baseline concentration of MMP7 between IPF patients with or without disease progression, and short-term changes in its concentration could not reflect disease progression (Raghu et al., 2018; Khan et al., 2022). Here, MMP7 is linked to idiopathic pulmonary fibrosis.